Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | P14 - Poster Session 14

Thursday 04/27/23
11:45 AM - 12:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 CME credit
Event Timeline
11:45 AM - 12:45 PM EST Abstract 9-001 - Treatment Outcomes During Brivaracetam Treatment by Seizure Freedom Status at Baseline: Post hoc Analysis of a Real-world, US Study
Prashant Dongre, MD, MBBS
11:45 AM - 12:45 PM EST Abstract 9-002 - Cognitive debrief of the Clinical Global Impression of Improvement for Nonseizure Symptoms measure in Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS): The Caregiver Perspective
Drishti Shah, PhD
11:45 AM - 12:45 PM EST Abstract 9-003 - Efficacy, Safety, and Tolerability of Adjunctive Eslicarbazepine Acetate in Focal Seizure Patients With Focal to Bilateral Tonic-Clonic Seizures at Baseline
Steve S. Chung, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 9-004 - Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC): 3-Year Results From GWPCARE6 Open-Label Extension (OLE)
Jessica DuHaime, PharmD
11:45 AM - 12:45 PM EST Abstract 9-005 - Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study
Sean Stern
11:45 AM - 12:45 PM EST Abstract 9-006 - Seizure Outcomes With Cannabidiol (CBD) in Pediatric Versus Adult Patients With Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS): Subgroup Analysis of BECOME, a Caregiver Survey
Timothy B. Saurer, PhD
11:45 AM - 12:45 PM EST Abstract 9-007 - Cognitive and Behavioral Effects of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Final Data From an Open-label Follow-up Trial
Frank Tennigkeit, PhD
11:45 AM - 12:45 PM EST Abstract 9-008 - Nonseizure Outcomes With Cannabidiol (CBD) in Pediatric Versus Adult Patients With Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS): Subgroup Analysis of BECOME, a Caregiver Survey
Catherine L. Passariello, PhD
11:45 AM - 12:45 PM EST Abstract 9-009 - Assessing Biases in the Diagnosis of Psychogenic Non-Epileptic Spells (PNES)
Ramsha A. Bhutta, MD
11:45 AM - 12:45 PM EST Abstract 9-010 - Pregnancy and Breastfeeding: A Survey of People with Epilepsy about their Experiences and Attitudes
Denise Li, MD
11:45 AM - 12:45 PM EST Abstract 9-011 - Seizure Control in Women with Epilepsy Undergoing Assisted Reproductive Technology
Aisha Abdulrazaq, MBBS
11:45 AM - 12:45 PM EST Abstract 15-001 - SAFE-TE: Staff Awareness and Familiarity with Epilepsy through Technology and Education
Johnny Chen, Other
11:45 AM - 12:45 PM EST Abstract 15-003 - Online CME-Certified Expert Panel Discussion Improves Awareness Among Neurologists Regarding Seizure Freedom in Patients with Epilepsy
Thomas Finnegan, Jr., PhD
11:45 AM - 12:45 PM EST Abstract 15-004 - Creating a Sustainable Model for Epilepsy Transition with Objective Outcome Measurements
Elizabeth B. Edwards
11:45 AM - 12:45 PM EST Abstract 15-005 - A New Era in the Management of Rett Syndrome: Are Neurologists Ready for a Changing Management Landscape?
Carole Drexel
11:45 AM - 12:45 PM EST Abstract 3-001 - Patient Characteristics and Persistence Among Commercially Insured Patients With Multiple Sclerosis Initiating Cladribine Tablets
Chris M. Kozma
11:45 AM - 12:45 PM EST Abstract 3-002 - Unilateral ‘Ophthalmic nerve pattern’ of sensory loss from a demyelinating lesion in lateral cervical cord: a lesson in neuroanatomy
Mirza Omari, MD
11:45 AM - 12:45 PM EST Abstract 3-004 - Delayed Onset Cryptogenic Organizing Pneumonia in Alemtuzumab Treatment Patient
Yao Cheng, MBBS
11:45 AM - 12:45 PM EST Abstract 3-005 - Tolosa Hunt Syndrome, A Variant of Neuroinflammation: A Case Report
Jonathon Chon Teng Chio, PhD
11:45 AM - 12:45 PM EST Abstract 3-007 - Balo’s Concentric Sclerosis presenting as Sensorineural Hearing Loss
Anvita Potluri, MD
11:45 AM - 12:45 PM EST Abstract 3-008 - Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US
Aaron W. Abrams, MD
11:45 AM - 12:45 PM EST Abstract 3-009 - Cost, efficacy and safety comparison between early intensive and escalating strategies for multiple sclerosis: a Systematic Review and Meta-analysis
Leonardo Pipek, MD
11:45 AM - 12:45 PM EST Abstract 3-010 - Extended Interval Dosing of Ocrelizumab in Patients with Multiple Sclerosis Is Not Associated with Meaningful Differences in Disease Activity
Nicole Bou Rjeily, MD
11:45 AM - 12:45 PM EST Abstract 3-011 - Natalizumab Extended Interval Dosing (EID) is Associated with a Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) Compared with Every-4-Week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database
Lana Zhovtis Ryerson, MD
11:45 AM - 12:45 PM EST Abstract 3-012 - A Real-life study of Alemtuzumab in patients with Multiple Sclerosis: Kuwait’s Experience
Raed Alroughani, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 3-013 - Approach to Balancing Risk in Multiple Sclerosis Management: a Worldwide Practice Survey
Jodie Roberts, MD
11:45 AM - 12:45 PM EST Abstract 3-015 - Autologous hematopoietic stem cell transplantation in multiple sclerosis: A 20-year single center's experience in Mexico.
Mario E. Rodriguez Estrada, MD
11:45 AM - 12:45 PM EST Abstract 3-016 - The Role of C3 and C4 Complement Levels in the Differential Diagnosis of Central Nervous System Demyelinating Diseases
Asli Tuncer
11:45 AM - 12:45 PM EST Abstract 3-017 - Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis
Mattia Rosso, MD
11:45 AM - 12:45 PM EST Abstract 3-018 - Remote Monitoring of Neurological Patients
Marc Fischer
11:45 AM - 12:45 PM EST Abstract 12-001 - GFAP astrocytopathy presenting after COVID-19 infection with meningoencephalomyelitis and good recovery with immunotherapy
Kun-Wei Song, MD
11:45 AM - 12:45 PM EST Abstract 12-002 - Association between Diabetic Control (HbA1C) and the Risk of Developing Neurological Post-Acute Sequelae of COVID-19 (PASC)
Anam K. Shaikh
11:45 AM - 12:45 PM EST Abstract 12-003 - Fatigue, Somnolence and Depression Persist After Six Month In Recovered Individual After The Acute Covid-19
Rafael Joao
11:45 AM - 12:45 PM EST Abstract 12-004 - Fulminant Idiopathic Intracranial Hypertension Refractory to Treatment Associated to SARS-CoV-2: A Case Report
Ricardo Murguia Fuentes, MD
11:45 AM - 12:45 PM EST Abstract 12-005 - Long Covid Infection and Peripheral Neuropathy – Initial Presentation of Eosinophilic Granulomatous Polyangiitis (EGPA)
Kereisha Donegal, MD
11:45 AM - 12:45 PM EST Abstract 12-006 - Vaccine-induced immune thrombotic thrombocytopenia: an emerging disease during the COVID-19 pandemic
Naiade Couto, MD
11:45 AM - 12:45 PM EST Abstract 12-007 - Mild Encephalopathy with Reversible Splenium Lesion Associated with SARS-CoV-2 Infection
Atef Kokash, DO
11:45 AM - 12:45 PM EST Abstract 6-001 - A Nationwide Analysis of Ischemic Stroke Outcomes in Patients with COVID-19
Aayushi Garg, MBBS
11:45 AM - 12:45 PM EST Abstract 6-002 - Stroke Metrics During Covid-19: a Comprehensive Stroke Center Experience
Lara Carvalho de Oliveira
11:45 AM - 12:45 PM EST Abstract 6-003 - Compare complications during hospitalization between patients with and without dysphagia following acute stroke.
Sandra Badial
11:45 AM - 12:45 PM EST Abstract 6-004 - Outcomes of Multiple Sclerosis Patients following Admission for Acute Ischemic Stroke in the United States
Sailaja Sanikommu, MBBS
11:45 AM - 12:45 PM EST Abstract 6-006 - Long Term Follow Up of Patients with Stroke after SARS-CoV-2 infection and Incidence of Neurological Post-Acute Sequelae of COVID-19
Anam K. Shaikh
11:45 AM - 12:45 PM EST Abstract 6-007 - Does Elevated Inflammatory Markers Predict Functional Outcomes in Hospitalized Patients with COVID-19 and Acute stroke?
Omar Elsekaily, MBBS
11:45 AM - 12:45 PM EST Abstract 6-008 - Feasibility of the mobile app Destroke for clinical stroke monitoring based on the NIH Stroke Scale
Evan Noch, MD
11:45 AM - 12:45 PM EST Abstract 6-009 - Stroke Patient Characteristics Associated with 30-day Hospital Readmissions: A Retrospective, Intra-hospital network Study
Kevin Spiegler, MD, PhD
11:45 AM - 12:45 PM EST Abstract 6-010 - Rapid Development of High-Grade Dural Arteriovenous Fistula During Pregnancy: A Case Report
Nazanin Sheibani, MD
11:45 AM - 12:45 PM EST Abstract 6-012 - No Association Between Outcomes And Anti-Factor Xa Levels For Heparin Monitoring In Patients With Cerebral Venous Thrombosis
Yasaman Pirahanchi, MD
11:45 AM - 12:45 PM EST Abstract 6-013 - Risk Factors and Outcome of Cerebrovascular Complications in Transplant Recipients
Angel J. Cadena Tejada, MD
11:45 AM - 12:45 PM EST Abstract 6-014 - A Novel Mechanism of the “Three Territory Sign” in Acute Ischemic Stroke
Michael A. Figueroa, DO
11:45 AM - 12:45 PM EST Abstract 6-015 - Disorders of Consciousness and Delays in Ischemic Stroke Treatment
Benjamin M. Jadow
11:45 AM - 12:45 PM EST Abstract 6-016 - A Retrospective Analysis of Co-morbidities in Stroke Patients with COVID
Mohammad A. Sheikh, MBBS
11:45 AM - 12:45 PM EST Abstract 6-017 - Association of Blood Pressure Parameters in Unsecured Aneurysmal Subarachnoid Hemorrhage and Outcomes
Ariyaporn Haripottawekul
11:45 AM - 12:45 PM EST Abstract 6-019 - Blunt Traumatic Cerebrovascular Injury and Stroke: The Need for a High Index of Suspicion when Initial Vascular Imaging is Negative - A Single Center Case Series.
Ahmer Asif, MD
11:45 AM - 12:45 PM EST Abstract 6-020 - Study of Risk Factors and Outcome Evaluation in Patients with Stroke with Intracranial versus Extracranial Atherosclerotic Arterial Disease
Aashka Ponda, Other
11:45 AM - 12:45 PM EST Abstract 6-022 - Iron Deficiency Anemia and Ischemic Stroke in Premenopausal Women
Hanah A. Imam, MBBS
11:45 AM - 12:45 PM EST Abstract 6-023 - Acute Neurological Consultation in Patients with Cervical Orthopedic Intervention
Ashwini Gadalay, MBBS
11:45 AM - 12:45 PM EST Abstract 6-024 - Age-related Macular Degeneration, Incident Ischemic Stroke, and Cognitive impairment
Bhrugun Anisetti, MBBS
11:45 AM - 12:45 PM EST Abstract 6-025 - Relationships among Hospital Acute Ischemic Stroke Volumes, Hospital Characteristics, and Outcomes in the US
Louise M. McCarthy, MB BCh BAO
11:45 AM - 12:45 PM EST Abstract 6-026 - Prevalence of Neurogenic Stress Cardiomyopathy in Acute Ischemic Stroke and Relationship with Leukocytosis
Laura Naydovich, MD
11:45 AM - 12:45 PM EST Abstract 6-027 - Clinical, Anatomical, and Demographic features associated with the use of Patient-Specific Advanced Visualization Modeling in Cerebrovascular Disease
Vishal N. Bhimarasetty, MSc
11:45 AM - 12:45 PM EST Abstract 6-028 - Patients with COVID-19 Infection and Stroke have Higher than Expected Mortality, Regardless of the Primary Presentation
Jintong Liu
11:45 AM - 12:45 PM EST Abstract 6-029 - Outcome of Lacunar vs Non-lacunar Infarcts in a Prospective Stroke Database
Prabandh R. Buchhanolla, MBBS
11:45 AM - 12:45 PM EST Abstract 6-030 - Unvaccinated: An unrecognized risk factor for stroke
Divya Gupta, MD
11:45 AM - 12:45 PM EST Abstract 6-031 - Systemic inflammatory response syndrome deteriorates the outcomes of mechanical thrombectomy in acute stroke
Mostafa Jafari, MD
11:45 AM - 12:45 PM EST Abstract 6-032 - Metabolic Syndrome as a Risk Factor in Latin American Patients with Intracerebral Hemorrhage
Enrique Gomez Figueroa, MD, MSc
11:45 AM - 12:45 PM EST Abstract 7-001 - Association of Life’s Simple 7 with Brain Imaging Outcomes Among Hispanics/Latinos. Results from the Study of Latinos-Investigation of Neurocognitive Aging-MRI (SOL-INCA-MRI) Ancillary Study
Fernando D. Testai, MD, PhD, FAAN
11:45 AM - 12:45 PM EST Abstract 7-002 - Ethnic Disparities in Clinical Presentation of Patients with Early-Onset Alzheimer’s Disease
Meredith F. Yang
11:45 AM - 12:45 PM EST Abstract 7-003 - Examining Age-Specific Barriers and Facilitators to Research Participation in Underrepresented Americans
Gregory S. Day, MD, MSc, FAAN
11:45 AM - 12:45 PM EST Abstract 7-004 - The Cost Burden of Alzheimer’s Disease on Care Partners
Luis Rafael Solís-Tarazona, MD
11:45 AM - 12:45 PM EST Abstract 7-005 - Online CME-certified Survey Identifies Sources for Clinical Practice Gaps Among Neurologists and PCPs Regarding the Early Recognition of Alzheimer’s Disease
11:45 AM - 12:45 PM EST Abstract 7-006 - Financial Toxicity in Dementia Caregiving
Danielle M. Hart
11:45 AM - 12:45 PM EST Abstract 7-007 - The Impact of Social History on the Development of Alzheimer’s Disease
Madisen L. Faulkner
11:45 AM - 12:45 PM EST Abstract 7-009 - Cognitive Health in Underrepresented Populations—Early Learnings From INTUITION: A Brain Health Study
Matt Hobbs
11:45 AM - 12:45 PM EST Abstract 7-010 - The Impact of Alzheimer’s Disease on Care Partners
Luis Rafael Solís-Tarazona, MD
11:45 AM - 12:45 PM EST Abstract 1-001 - Evaluating the Performance of the IMPACT Model in the Prehospital TXA for TBI Trial
H. E. Hinson, MD, MCR, FAAN
11:45 AM - 12:45 PM EST Abstract 1-002 - Relationship Between White Matter Hyperintensities and Blood Biomarkers of Axonal Injury and White Matter Integrity
Abbie Chan
11:45 AM - 12:45 PM EST Abstract 1-003 - Relationship Between Time of Hospital Arrival and Clinical and Fluid Biomarker Outcomes in Traumatic Brain Injury
Aaron Anandarajah
11:45 AM - 12:45 PM EST Abstract 1-004 - Interventions to Optimize Spinal Cord Perfusion in Patients with Acute Traumatic Spinal Cord Injury: An Updated Systematic Review
David E. Kahn, MD
11:45 AM - 12:45 PM EST Abstract 1-005 - Resting State fMRI for Neuroprognostication in Traumatic Brain Injury: Clinical Experience of Evaluation for Covert Consciousness and Epileptogenic Networks in Acute Coma
Nikoloz Karazanashvili, MD
11:45 AM - 12:45 PM EST Abstract 1-006 - Delayed Posttraumatic Intracranial Hemorrhage in a Patient not on Antithrombotic Therapy
Victoria Q. Tay
11:45 AM - 12:45 PM EST Abstract 10-001 - Early Post Radiation Neuropathy: Complex Pathogenesis Including Microvasculitis and Tumor Spread
Michael P. Skolka, MD
11:45 AM - 12:45 PM EST Abstract 10-002 - Title: Exploring Relationships Between Ultrasound-Measured Pre-Operative Median Nerve Echointensity and Successful Carpal Tunnel Release -A Retrospective Review
Yohei Harada, MD
11:45 AM - 12:45 PM EST Abstract 10-003 - Morphological Changes on Neuromuscular Ultrasound in Nerves Distal to Gunshot Injuries
Patrick Fagan, MD
11:45 AM - 12:45 PM EST Abstract 10-004 - Serum Neurofilament Light Chain Levels in Small Fiber Neuropathy Patients with Skin Denervation and Ongoing Neuropathic Symptoms
Daniela N. Zohar, MD
11:45 AM - 12:45 PM EST Abstract 10-005 - Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life
Catherine W. Imossi
11:45 AM - 12:45 PM EST Abstract 10-006 - A Phase 2/3 Placebo-Controlled, Parallel Group, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: the ARISE study
Lisa M. Ford, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 10-007 - Small Vessel Vasculitis in Small Fiber Neuropathy with TS-HDS, FGFR-3, or Plexin D1 antibodies
Lawrence A. Zeidman, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 10-008 - Anti-Plexin D1 Antibodies in Axonal Polyneuropathy
Isheeta S. Govardhan
11:45 AM - 12:45 PM EST Abstract 10-009 - Description of a Rare Compound Heterozygous Transthyretin Mutation Val30Met/Val122Ile Conferring Early Onset Hereditary Amyloidosis with Severe Features
Joshua Nardin, DO
11:45 AM - 12:45 PM EST Abstract 10-010 - Characterization of Polyneuropathy in Patients Receiving Enfortumab Vedotin for the Treatment of Metastatic Urothelial Carcinoma
Melody Badii, MD
11:45 AM - 12:45 PM EST Abstract 10-011 - Clinical Characteristics, Treatment and Outcomes of Patients with Paraneoplastic Neuropathies. A Retrospective Single-Center Study in Argentina.
Francisco Caiza Zambrano
11:45 AM - 12:45 PM EST Abstract 10-012 - Presentations of Peripheral Neuropathy with Anti-Fibroblast Growth Factor Receptor-3 Antibodies
Clover Youn, MD
11:45 AM - 12:45 PM EST Abstract 10-013 - Surgical Release of Ulnar and Median Nerves in CMT1A: Prevention and Treatment of a Second Hit
Will McKeen, MD
11:45 AM - 12:45 PM EST Abstract 10-014 - A Case of Charcot-Marrie-Tooth 1F Mimicking Chronic Inflammatory Demyelinating Polyradiculopathy
Nasrin Rahimian, MD
11:45 AM - 12:45 PM EST Abstract 10-015 - Evidence of Lumbosacral Plexus Involvement on MR Neurography in Early Guillain-Barré Syndrome
Ashley Weng, MD
11:45 AM - 12:45 PM EST Abstract 4-001 - Falsely Reassuring Head CT Delays Diagnosis in Childhood Arterial Ischemic Stroke
Vivian Chiang, MD
11:45 AM - 12:45 PM EST Abstract 4-003 - Migraine Disability Evaluation in Indian Children by Pediatric Migraine Disability Assessment (PedMIDAS) Scale: A Prospective Observational Study
Lokesh Saini, DM
11:45 AM - 12:45 PM EST Abstract 4-004 - Cow’s Milk Anemia In Childhood Manifesting As Severe Cerebral Venous Sinus Thrombosis
Catherine M. Amlie-Lefond, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 4-005 - Utility of Neuroimaging in Children Presenting to the Emergency Department with Altered Mental Status
Giovanni Castellucci, MD, MS
11:45 AM - 12:45 PM EST Abstract 4-006 - Peripheral Neuropathy in a Pediatric ALL Patient
Douglas A. Wells, Jr., MD
11:45 AM - 12:45 PM EST Abstract 4-007 - Neurocognitive Manifestations of Individuals with NF1 Microdeletions
Jenny P. Garzon, MD
11:45 AM - 12:45 PM EST Abstract 4-008 - Development and internal validation of a clinical risk score to predict incident renal and pulmonary tumors in people with tuberous sclerosis complex
Frédéric Loubert
11:45 AM - 12:45 PM EST Abstract 4-009 - Outcomes in Children with Shaken Baby Syndrome and Seizures
Katelyn Stebbins
11:45 AM - 12:45 PM EST Abstract 4-010 - Metabolic Stroke as a Clinical Manifestation of Zhu-Tokita-Takenouchi-Kim (ZTTK) Syndrome: A Case Series
Jorge L. Morales, MD
11:45 AM - 12:45 PM EST Abstract 4-012 - Trends in Early MRI Utilization in Critically Ill Children with Severe TBI: a Single Center Experience, 2010-2021
Anna Janas, MD, PhD
11:45 AM - 12:45 PM EST Abstract 13-002 - Under Pressure: Neurocysticercosis Manifests Itself as Intracranial Hypertension
Erin H. Britt, MD
11:45 AM - 12:45 PM EST Abstract 13-004 - Neurotoxoplasmosis: a 5-year story in the Dominican Republic
María F. Cedeño, MD
11:45 AM - 12:45 PM EST Abstract 13-005 - Post-malaria neurological syndrome - chronic ailments of the acute parasitic infection.
Maria Andreina Hernandez, MD
11:45 AM - 12:45 PM EST Abstract 5-001 - Acetyl-L-Leucine for Niemann-Pick type C: A Multinational Double-blind Randomized Placebo-controlled Crossover Study
Tatiana T. Bremova-Ertl, MD, PhD
11:45 AM - 12:45 PM EST Abstract 5-002 - Lamotrigine as a First-line Agent in the Management of Paroxysmal Kinesigenic Dyskinesia
Heather Leduc-Pessah, MD, PhD
11:45 AM - 12:45 PM EST Abstract 5-003 - Vertical supranuclear gaze palsy in Primary Familial Brain Calcification associated with a novel SLC20A2 mutation
Nikolai Gil D. Reyes, MD
11:45 AM - 12:45 PM EST Abstract 5-004 - Frequency, Classification, and Timing of Movement Disorders in Rapidly Progressive Dementia
Pierpaolo Turcano, MD
11:45 AM - 12:45 PM EST Abstract 5-005 - A familial case of Congenital Mirror Movement (CMM) Syndrome Associated With A Novel DCC Variant
Ankur Nayyar, MD
11:45 AM - 12:45 PM EST Abstract 5-006 - Identification of novel compound heterozygous mutation in Niemann-Pick disease type C gene
Ali H. Abusrair, MD
11:45 AM - 12:45 PM EST Abstract 5-007 - A Cross-Sectional Evaluation of Health Resource Use in Patients with Functional Neurological Disorders Referred to a Tertiary Neuroscience Centre
Brian W. O'Mahony, MD
11:45 AM - 12:45 PM EST Abstract 5-008 - Pain Reduction in Adult Patients with Limb Spasticity Following a Single IncobotulinumtoxinA Injection: an Analysis of Pooled Data from Phase 2 and 3 Studies
Jorg Wissel
11:45 AM - 12:45 PM EST Abstract 5-009 - The Economic Cost of Functional Neurological Disorders: A Systematic Review
Brian W. O'Mahony, MD
11:45 AM - 12:45 PM EST Abstract 5-013 - Safety of opicapone after 5 years of post-marketing experience worldwide
Luis Guedes, MD
11:45 AM - 12:45 PM EST Abstract 5-014 - Consistent Effects of Once-Daily Opicapone 50 mg on COMT Activity Across Participants: A Pooled Post Hoc Analysis of Two Phase 1 Studies
Eric Jen
11:45 AM - 12:45 PM EST Abstract 5-015 - Perspectives on Parkinson's Disease Medications: A Qualitative Study of People with Parkinson's Disease
Steve Arcona, PhD
11:45 AM - 12:45 PM EST Abstract 5-016 - A novel retromer stabilizer as a potential treatment for Parkinson’s disease
Michele Persico, MD
11:45 AM - 12:45 PM EST Abstract 2-001 - Suicide in Veterans with Post-Traumatic Headache: An Analysis of Health Systems Data
Sarah Anthony, Other
11:45 AM - 12:45 PM EST Abstract 2-002 - The relationship between gender, peer victimization, mental health, and frequent headaches in adolescents: A Canadian population-based observational study
Christelle Nilles, MD
11:45 AM - 12:45 PM EST Abstract 2-003 - Clinical characteristics and factors associated with headaches following COVID-19 vaccination: a cross-sectional cohort study
Saba Ilkhani, MD
11:45 AM - 12:45 PM EST Abstract 2-004 - Migraine Prevalence in Gender Identity Minorities
David C. Wegener, Jr., MD
11:45 AM - 12:45 PM EST Abstract 2-005 - Twenty years of population-based studies in US adults with migraine reveal minimal improvement in care
Julia L. Jones, PhD
11:45 AM - 12:45 PM EST Abstract 2-006 - Different Experiences in Chronic Migraine Etiology, Treatment and Comorbidities of Hawaii’s Ethnic Groups
Enrique Carrazana
11:45 AM - 12:45 PM EST Abstract 2-007 - Health concerns and treatment perspectives among US adults with current versus previous high-frequency headache/migraine and acute medication overuse: The Harris Poll Migraine Report Card Survey
Amaal J. Starling, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 2-008 - Treatment Effects of Celecoxib Oral Solution in Migraine With Aura and Without Aura: Post-Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials
Stewart J. Tepper, MD
11:45 AM - 12:45 PM EST Abstract 2-009 - Efficacy of Celecoxib Oral Solution in Adults With and Without Baseline Nausea: Post Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials in the Acute Treatment of Migraine
Stewart J. Tepper, MD
11:45 AM - 12:45 PM EST Abstract 2-010 - Transnasal Evaporative Cooling Device for Migraine: A Randomized Trial
Larry Charleston IV, MD, MSc, FAHS
11:45 AM - 12:45 PM EST Abstract 2-011 - Safety of Concomitant Triptan and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients
Sheena K. Aurora, MD
11:45 AM - 12:45 PM EST Abstract 2-012 - Assessing the Synergistic effect of Vitamin supplementation and Migraine preventative management in children and adolescents with chronic migraine- retrospective cohort analysis
Peyton I. Crest
11:45 AM - 12:45 PM EST Abstract 11-001 - MALT Lymphoma Presenting as Symptomatic Optic Neuritis: A Case Report
Dan Tong Jia, MD
11:45 AM - 12:45 PM EST Abstract 11-002 - All that enhances is not cancer: Cerebral amyloid angiopathy mimicking leptomeningeal enhancement in the two patients with advanced cancer
Sadia Waheed, MBBS
11:45 AM - 12:45 PM EST Abstract 11-003 - A Case of CNS Lymphoma Imitating Post-Vaccination ADEM
Samuel Frank, MD
11:45 AM - 12:45 PM EST Abstract 11-004 - CNS Aspergillosis Following BTK Inhibitors Mimicking Secondary CNS Lymphoma – A Case Series
Naina Murthy
11:45 AM - 12:45 PM EST Abstract 11-005 - Stroke Like Presentation Of CNS Lymphoma
Deema Sawass Najjar, MD
11:45 AM - 12:45 PM EST Abstract 11-006 - A Case Report of Primary Central Nervous System T-Cell Lymphoma Mimicking Autoimmune Encephalitis
Kristi M. Anderson, DO
Faculty Disclosures
Evan Noch, MD Dr. Noch has received personal compensation for serving as an employee of Destroke, Inc.. Dr. Noch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lexeo Therapeutics. Dr. Noch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra, Inc.. Dr. Noch has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Imedview, Inc.. Dr. Noch has stock in Destroke, Inc..
David N. Lieberman, MD, PhD Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene.
Matt T. Bianchi, MD, PhD No disclosure on file
Veronica Rivas Veronica Rivas has nothing to disclose.
Benjamin M. Jadow Mr. Jadow has nothing to disclose.
Sneha Mantri, MD Dr. Mantri has received personal compensation in the range of $0-$499 for serving as a Consultant for Deep Brain Innovations, LLC. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grey Matter Technology. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research.
Todd Grinnell, PhD Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Amit Bhardwaj, MD No disclosure on file
Anvita Potluri, MD Dr. Potluri has nothing to disclose.
Yao Cheng, MBBS Dr. Cheng has nothing to disclose.
No disclosure on file
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Catherine M. Amlie-Lefond, MD, FAAN Dr. Amlie-Lefond has nothing to disclose.
Paola Sandroni, MD, PhD, FAAN Dr. Sandroni has nothing to disclose.
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Med-IQ. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Everyday Health. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura.
Ariane Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Nikolai Gil D. Reyes, MD Dr. Reyes has nothing to disclose.
Lokesh Saini, DM Dr. Saini has nothing to disclose.
Angel J. Cadena Tejada, MD Dr. Cadena Tejada has nothing to disclose.
Emily L. Evans, MD Dr. Evans has received personal compensation for serving as an employee of EMD Serono. Dr. Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Evans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Evans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis.
Mayra Estrella No disclosure on file
Hector Gonzalez No disclosure on file
Kurt Olson Kurt Olson has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Kurt Olson has stock in Neurocrine Biosciences Inc.
Marie Y. Davis, MD, PhD The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation.
H. E. Hinson, MD, MCR, FAAN Dr. Hinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid AI. Dr. Hinson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Parneet K. Grewal, MD Dr. Grewal has nothing to disclose.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Carnot. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly Eli and Company. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Torrent Pharmaceuticals Mexico. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbvie allergan.
Fernando D. Testai, MD, PhD, FAAN Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Swanson Martin & Bell, LLP. Dr. Testai has received publishing royalties from a publication relating to health care.
Jasmine S. Coles Miss Coles has nothing to disclose.
Manu S. Goyal, MD Dr. Goyal has received stock or an ownership interest from IBM. The institution of Dr. Goyal has received research support from NIH. Dr. Goyal has received personal compensation in the range of $0-$499 for serving as a Conference attendee with Capital Medical University, Shandong Madic Technology Co Ltd, Tancheng Talent Office.
Winston Chiong, MD The institution of Dr. Chiong has received research support from the National Institutes of Health. The institution of Dr. Chiong has received research support from the Dana Foundation. Dr. Chiong has received personal compensation in the range of $500-$4,999 for serving as a member, NeuroEthics Working Group with National Institutes of Health.
Theron C. Casper, PhD The institution of Dr. Casper has received research support from NIH. The institution of Dr. Casper has received research support from The National Multiple Sclerosis Society. The institution of Dr. Casper has received research support from Roche. The institution of Dr. Casper has received research support from Biogen.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Martha Daviglus No disclosure on file
Liliana A. Ramirez-Gomez, MD The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
Gregory D. Cascino, MD, FAAN Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Korak Sarkar, MD, MHDS, FAAN An immediate family member of Dr. Sarkar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Canon Medical. Dr. Sarkar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medical-legal cases. Dr. Sarkar has a non-compensated relationship as a Senior Editor with Journal of Medical Extended Reality that is relevant to AAN interests or activities.
Luca Bartolini, MD, FAAN Dr. Bartolini has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology.
M.V.Padma Srivastava No disclosure on file
Amy L. Phillips, PharmD Amy L. Phillips, PharmD has received personal compensation for serving as an employee of EMD Serono, Inc.
Arturo I. Benitez, MD Dr. Benitez has received personal compensation for serving as an employee of Takeda.
Ngoc Minh D. Le, MD Dr. Le has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Le has stock in Greenwich Biosciences.
Rachel Pearson, MD Dr. Pearson has received personal compensation for serving as an employee of MDReview. The institution of Dr. Pearson has received research support from Pediatric Subspecialty Faculty.
Heather Leduc-Pessah, MD, PhD Dr. Leduc-Pessah has nothing to disclose.
Eric R. Eggenberger, DO, FAAN Dr. Eggenberger has nothing to disclose.
Kristen M. Krysko, MD Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Krysko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Krysko has received research support from MS Society of Canda. The institution of Dr. Krysko has received research support from Roche.
Kelsey M. Smith, MD The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Serena Orr, MD The institution of Dr. Orr has received research support from Alberta Children's Hospital Research Institute. The institution of Dr. Orr has received research support from Canadian Institutes of Health Research. The institution of Dr. Orr has received research support from Department of Pediatrics, University of Calgary. Dr. Orr has received publishing royalties from a publication relating to health care. Dr. Orr has a non-compensated relationship as a associate editor with Headache: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with Neurology that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with American Migraine Foundation that is relevant to AAN interests or activities.
Dan Tong Jia, MD Dr. Jia has nothing to disclose.
Raja Hassan Imtiaz, MBBS Dr. Imtiaz has nothing to disclose.
Sanjeev K. Bhoi, MD, MBBS Dr. Bhoi has nothing to disclose.
Jenny Schmidt, MD Dr. Schmidt has nothing to disclose.
Joab Chapman, MD, PhD Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Daniela N. Zohar, MD Dr. Zohar has nothing to disclose.
Niraj Kumar, MD Dr. Kumar has nothing to disclose.
Shibeshih Belachew, MD Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
John R. Absher, MD, FAAN Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehabilitation Alternative Services, Inc.. Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Butler, Means, Evins and Browne, P.A..
Nihal Satyadev, MD, MPH Mr. Satyadev has nothing to disclose.
Christelle Nilles, MD Dr. Nilles has received research support from French Gilles de la Tourette Association. Dr. Nilles has received research support from Owerko Centre of Alberta Children's Hospital Research Institute.
Sucharita Anand No disclosure on file
Ana Ponciano, MD Dr. Ponciano has nothing to disclose.
Laura Fonseca No disclosure on file
Nicholas Milano, MD Dr. Milano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson kelly.
Nuri Jacoby, MD, FAAN Dr. Jacoby has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Novartis. The institution of Dr. Graff-Radford has received research support from AbbVie. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Paula E. Voinescu, MD The institution of Dr. Voinescu has received research support from Epilepsy Foundation of New England. The institution of Dr. Voinescu has received research support from BWH - Connors Center. The institution of an immediate family member of Dr. Voinescu has received research support from American Epilepsy Society. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Physicians' Education Resouce. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Phillipines League Against Epilepsy. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with Epilepsy Ireland that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Gary S. Gronseth, MD, FAAN Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Nicole Coolbaugh, Other Ms. Coolbaugh has nothing to disclose.
Anna Janas, MD, PhD Dr. Janas has nothing to disclose.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Gordon Loewen Gordon Loewen has received personal compensation for serving as an employee of Neurocrine. Gordon Loewen has received stock or an ownership interest from Neurocrine. Gordon Loewen has received intellectual property interests from a discovery or technology relating to health care.
Nolan Campbell Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
Wassim Tarraf No disclosure on file
Philippe Major, MD Dr. Major has nothing to disclose.
Lori Lebson Lori Lebson has nothing to disclose.
Emmanuelle Waubant, MD, PhD, FAAN Dr. Waubant has received personal compensation in the range of $500-$4,999 for serving as a Consultant for emerald pharmaceuticals. Dr. Waubant has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Biogen. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Harry Zobel, Jr., DO Dr. Zobel has nothing to disclose.
Leslie A. Benson, MD The institution of Dr. Benson has received research support from ROHHAD Fight, Inc. The institution of Dr. Benson has received research support from Shore Foundation. The institution of Dr. Benson has received research support from Alexion Pharmacuticals. The institution of Dr. Benson has received research support from Biogen, Inc. The institution of Dr. Benson has received research support from NIH. Dr. Benson has received personal compensation in the range of $0-$499 for serving as a consultant with MA Department of public health. Dr. Benson has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with National vaccine injury compensation program.
Darshil Shah, MBBS Dr. Shah has nothing to disclose.
Tomas Kalincik Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Federico J. Rodriguez-Porcel, MD An immediate family member of Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anmeal. Dr. Rodriguez-Porcel has received publishing royalties from a publication relating to health care.
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Surekha Dabla, MD Dr. Dabla has nothing to disclose.
Divya Gupta, MD Dr. Gupta has nothing to disclose.
Kamleshun Ramphul No disclosure on file
Lisette Arnaud-Hevi No disclosure on file
Enrique Carrazana Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurelis, Alexza, Zogenix. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences. Enrique Carrazana has stock in Neurelis, Marinus, .
Susan Rowell, MD, MCR Dr. Rowell has nothing to disclose.
Raimundo M. Brito Neto, Sr., MD Dr. Brito Neto has nothing to disclose.
Olga Klepitskaya, MD, FAAN Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Marcela Uribe Roca The institution of Marcela Uribe Roca has received research support from Roche.
Kristen Fisher, DO Dr. Fisher has nothing to disclose.
Elijah M. Persad-Paisley Mr. Persad-Paisley has nothing to disclose.
Jenny P. Garzon, MD Dr. Garzon has nothing to disclose.
Judie B. Gutierrez, PhD Dr. Gutierrez has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Gutierrez has stock in Impel Pharmaceuticals.
Birce D. Taskin, MD Dr. Taskin has nothing to disclose.
Quynh Vo, MD Dr. Vo has nothing to disclose.
Linda Gallo No disclosure on file
Nagagopal Venna, MBBS, FAAN Dr. Venna has nothing to disclose.
Jonathon Chon Teng Chio, PhD Dr. Chio has nothing to disclose.
Kara R. Melmed, MD Dr. Melmed has nothing to disclose.
Victoria Q. Tay Miss Tay has nothing to disclose.
Carla M. Francisco, MD Dr. Francisco has nothing to disclose.
E M. Bebin, MD Dr. Bebin has received personal compensation for serving as an employee of Springworks Therapeutics. Dr. Bebin has received personal compensation for serving as an employee of Apertura Gene Therapy. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apertura. The institution of Dr. Bebin has received research support from NINDS. The institution of Dr. Bebin has received research support from FDA Orphan Drug Program.
Julia Carlson, MD Dr. Carlson has nothing to disclose.
Joshua Nardin, DO Dr. Nardin has nothing to disclose.
Timothy B. Saurer, PhD Dr. Saurer has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Saurer has stock in Jazz Pharmaceuticals.
Prashant Dongre, MD, MBBS Dr. Dongre has received personal compensation for serving as an employee of UCB Inc. Dr. Dongre has stock in UCB Inc.
Muhammed Ikbal Arvas, MD Dr. Arvas has nothing to disclose.
Alexis Angelette, MD Miss Angelette has nothing to disclose.
Navreet Kaur, MBBS Dr. Kaur has nothing to disclose.
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Adeolu O. Morawo, MD Dr. Morawo has nothing to disclose.
Shawn Moore, MD Dr. Moore has nothing to disclose.
Marc Fischer Marc Fischer has nothing to disclose.
Roopa Sharma, MD Dr. Sharma has nothing to disclose.
Sharon Poisson, MD The institution of Dr. Poisson has received research support from Biogen.
Wesley Kerr, MD, PhD Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiTel. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from American Academy of Neurology. Dr. Kerr has received publishing royalties from a publication relating to health care.
Mariana R. Brito, MD No disclosure on file
Will McKeen, MD Dr. McKeen has nothing to disclose.
Roberto Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Alexander Carvajal- Gonzalez, MD, PhD Dr. Carvajal- Gonzalez has nothing to disclose.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care.
Paresh Zanzmera, MD Dr. Zanzmera has nothing to disclose.
Marcus Vinicius R. Pinto, MD Dr. Pinto has nothing to disclose.
Jose Murguia Fuentes No disclosure on file
William E. Rosenfeld, MD, FAAN The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Alexander Sellers, MD Dr. Sellers has nothing to disclose.
Nicole R. Nissim, PhD Dr. Nissim has nothing to disclose.
Luis Magalhaes Luis Magalhaes has received personal compensation for serving as an employee of BIAL-Portela & Cª, S.A..
Eric Pappert Eric Pappert has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Rimas V. Lukas, MD Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Lukas has received research support from BMS. The institution of Dr. Lukas has received research support from BrainUp. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from Ziopharm.
Fabrizio Stocchi Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Judith Goldberg No disclosure on file
Rajesh Pahwa, MD, FAAN Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allevion. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Photopharmics. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sun Biopharma. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Biohaven. The institution of Dr. Pahwa has received research support from EIP. The institution of Dr. Pahwa has received research support from Amneal. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theranexus. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Voyager. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Annovis. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Praxis. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB.
Samir Patel, MD, DNB Dr. Patel has nothing to disclose.
Lauren DiSalvo, DO Dr. DiSalvo has nothing to disclose.
Samar F. Ahmed, MD Dr. Ahmed has nothing to disclose.
Pantelis P. Pavlakis, MD Dr. Pavlakis has nothing to disclose.
Areej Nauman Miss Nauman has nothing to disclose.
Shyamal C. Bir, MD Dr. Bir has nothing to disclose.
Stacy S. Wu, MD Dr. Wu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc. Dr. Wu has stock in Novartis.
Sara Habib, MD, MBBS Dr. Habib has nothing to disclose.
Nancy Wang, MD Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seattle Genetics. The institution of Dr. Wang has received research support from Merck. Dr. Wang has received publishing royalties from a publication relating to health care.
Holly A. Shill, MD, FAAN Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Tamara M. Pringsheim, MD, FAAN The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Mary R. Rensel, MD, FAAN Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech .
Russell E. Bartt, MD, FAAN Dr. Bartt has nothing to disclose.
David C. Preston, MD, FAAN Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Philip W. Tipton, MD Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Christopher D. Geiger, MD Dr. Geiger has nothing to disclose.
Neishay Ayub, MD The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Alvee Saluja, DM Dr. Saluja has nothing to disclose.
Roger E. Kelley, Jr., MD, FAAN Dr. Kelley has nothing to disclose.
Zehra Husain, MD Dr. Husain has a non-compensated relationship as a member, Medical Board of Directors with Epilepsy Foundation of Eastern Pennsylvania that is relevant to AAN interests or activities.
Hong Sun, MD, PhD Dr. Sun has received personal compensation for serving as an employee of Janssen.
Mustafa Jaffry Mr. Jaffry has nothing to disclose.
Erin H. Britt, MD Dr. Britt has nothing to disclose.
Carlos Alva-Diaz No disclosure on file
Prabandh R. Buchhanolla, MBBS Dr. Buchhanolla has nothing to disclose.
Stephen B. Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Maria Elisa Samaniego, MD Dr. Samaniego has nothing to disclose.
Hina N. Dave, MD Dr. Dave has nothing to disclose.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Kyriakos Martakis No disclosure on file
Jovana Lubarda Jovana Lubarda has nothing to disclose.
Catherine W. Imossi Ms. Imossi has nothing to disclose.
Gregory Talavera No disclosure on file
Jasem Y. Al-Hashel, MD Dr. Al-Hashel has nothing to disclose.
Carly Tucci No disclosure on file
Jason J. Sico, MD, FAAN Dr. Sico has nothing to disclose.
Christian J. Burrell, MD Dr. Burrell has nothing to disclose.
Joon H. Uhm, MD, FRCP(C), FAAN Dr. Uhm has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Lab.
Catherine Larochelle, MD Dr. Larochelle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Novartis, Sanofi-Genzyme, Alexion, EMD-Serono, FIND therapeutics, Actelion. The institution of Dr. Larochelle has received research support from Université de Montréal-CHUM.
Aravind Ganesh No disclosure on file
Mailam Eltity Dr. Eltity has nothing to disclose.
Fabiola Serrano-arias No disclosure on file
Mirza Omari, MD Dr. Omari has nothing to disclose.
Naina Murthy Ms. Murthy has nothing to disclose.
Vishal N. Bhimarasetty, MSc Mr. Bhimarasetty has nothing to disclose.
Deena A. Haque Ms. Haque has nothing to disclose.
Aila Rahman Miss Rahman has nothing to disclose.
Jeremy Abramson No disclosure on file
Solmaz Ramezani Hashtjin, MD Dr. Ramezani Hashtjin has nothing to disclose.
Mazieyar Azad, MD Dr. Azad has nothing to disclose.
Michael D. Weiss, MD, FAAN Dr. Weiss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Elizabeth Crabtree-Hartman, MD Dr. Crabtree-Hartman has nothing to disclose.
Madisen L. Faulkner Miss Faulkner has nothing to disclose.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
José María Benítez Salazar Mr. Benítez Salazar has nothing to disclose.
Jonadab Dos Santos Silva Mr. Dos Santos Silva has nothing to disclose.
Ashok Kumar, MD Dr. Kumar has nothing to disclose.
Jeffrey Andrews No disclosure on file
George K. Harrold, MD Dr. Harrold has nothing to disclose.
Melissa Armstrong, MD, MSc, FAAN The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
John Leever, MD Dr. Leever has nothing to disclose.
Teri Schreiner, MD, MPH, FAAN The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Enrique Gomez Figueroa, MD, MSc Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM.
Pooja Jindal, Sr., MD Dr. Jindal has nothing to disclose.
Roger J. Porter, MD, FAAN Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received publishing royalties from a publication relating to health care.
Simona Treidler, MD Dr. Treidler has nothing to disclose.
Mohammed E. Abunaib, MD, MBBS Dr. Abunaib has nothing to disclose.
Maxwell A. Greene, MD Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Dysimmune Diseases Foundation .
Mario E. Rodriguez Estrada, MD Dr. Rodriguez Estrada has nothing to disclose.
Justyna Sarna, MD No disclosure on file
Rahul Sasane, PhD Dr. Sasane has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Sasane has stock in Cerevel Therapeutics.
Luis Rafael Solís-Tarazona, MD Mr. Solís-Tarazona has received personal compensation for serving as an employee of Novo Nordisk A/S.
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
Simona Eleuteri No disclosure on file
Antonio Arauz, MD, PhD Dr. Arauz has nothing to disclose.
Ingemar S. Merkies, MD No disclosure on file
Lisa M. Ford, MD, FAAN Dr. Ford has received personal compensation for serving as an employee of Janssen . Dr. Ford has stock in Janssen.
Steven Kymes Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Yanal R. Shaheen, MD Dr. Shaheen has nothing to disclose.
Souvik Dubey No disclosure on file
Karan S. Dixit, MD Dr. Dixit has nothing to disclose.
Clarissa L. Yasuda, MD, PhD Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Florian P. Thomas, MD, PhD, MA, FAAN Dr. Thomas has received personal compensation for serving as an employee of Hackensack Meridian Health. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Spinal Cord Medicine. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Gravel & Shae. The institution of Dr. Thomas has received research support from University of Pennsylavania. Dr. Thomas has a non-compensated relationship as a Board Member, Metro New Jersey with National MS Society that is relevant to AAN interests or activities. Dr. Thomas has a non-compensated relationship as a Board Member with American Paraplegia Society that is relevant to AAN interests or activities.
Sulena Singh, MD No disclosure on file
Vivian Chiang, MD Dr. Chiang has nothing to disclose.
James J. Gugger, Jr., MD, PharmD Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
Robert Vann, PhD Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
Daniel Santos, MD Dr. Santos has nothing to disclose.
Sutapa Ray, PhD Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Mahinda Yogarajah, MD Dr. Yogarajah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MEWA. Dr. Yogarajah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Forensic Access. Dr. Yogarajah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Eopinex. The institution of Dr. Yogarajah has received research support from MRC. Dr. Yogarajah has received publishing royalties from a publication relating to health care.
Douglas A. Wells, Jr., MD Dr. Wells has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has nothing to disclose.
Elizabeth Gerard, MD Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of an immediate family member of Dr. Gerard has received research support from Novo Nordisk. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University).
Manasa Gunturu, MD Dr. Gunturu has nothing to disclose.
Frédéric Loubert Mr. Loubert has nothing to disclose.
Amir Dori, MD, PhD Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda . Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison Pharma. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Dr. Dori has received research support from Biogen. The institution of Dr. Dori has received research support from Pfizer. The institution of Dr. Dori has received research support from Alnylam therapeutics. Dr. Dori has received intellectual property interests from a discovery or technology relating to health care.
Aisha Abdulrazaq, MBBS Dr. Abdulrazaq has nothing to disclose.
Carlos Rodrigo Q. Vicuña Mr. Vicuña has nothing to disclose.
Deema Sawass Najjar, MD Dr. Sawass Najjar has nothing to disclose.
Xu Tang, DO Dr. Tang has nothing to disclose.
Fardin Nabizadeh III Mr. Nabizadeh has nothing to disclose.
Naiade Couto, MD Dr. Couto has nothing to disclose.
Andrea L. Schneider, MD, PhD Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Kristin Maher No disclosure on file
Peyton I. Crest Ms. Crest has nothing to disclose.
Thapat Wannarong, MD Dr. Wannarong has nothing to disclose.
Isheeta S. Govardhan Ms. Govardhan has nothing to disclose.
Lauren S. Talman, MD Dr. Talman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Oregon Federal Public Defenders Office. Dr. Talman has received personal compensation in the range of $500-$4,999 for serving as a panelist with HDSA.
Bhrugun Anisetti, MBBS Dr. Anisetti has nothing to disclose.
Angelica G. Montilla Miss Montilla has nothing to disclose.
Erica Kemp No disclosure on file
Aaron Anandarajah Mr. Anandarajah has nothing to disclose.
Maria Andreina Hernandez, MD Dr. Hernandez has nothing to disclose.
Ram Balu, MD Dr. Balu has nothing to disclose.
Ashwini Gadalay, MBBS Dr. Gadalay has received personal compensation for serving as an employee of State university of New york, upstate medical university.
Jose L. Torres, MD Dr. Torres has nothing to disclose.
Michael P. Skolka, MD Dr. Skolka has nothing to disclose.
Rachel E. Triay, MD Dr. Triay has nothing to disclose.
Jodie Roberts, MD An immediate family member of Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Roberts has received research support from Canadian Network of MS Clinics. Dr. Roberts has received research support from Rebecca Hotchkiss International Exchange Program. The institution of Dr. Roberts has received research support from University of Calgary Medical Group Helios Award. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis. Dr. Roberts has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with EMD Serono.
Jan-Peer Elshoff, PhD Dr. Elshoff has nothing to disclose.
Charles S. DeCarli, MD, FAAN Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH.
Aiden Meyer Mr. Meyer has received research support from Brown University - Undergraduate Teaching and Research Award.
Monroe Butler, MD, PhD Dr. Butler has received personal compensation for serving as an employee of Biogen. Dr. Butler has stock in Biogen.
Jason Viereck, MD, PhD Dr. Viereck has nothing to disclose.
Alessandro Tessitore Alessandro Tessitore has nothing to disclose.
Taylor Fields No disclosure on file
Alexander Feoktistov, MD, PhD Dr. Feoktistov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. Dr. Feoktistov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Feoktistov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Feoktistov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Feoktistov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Feoktistov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Feoktistov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Impel.
Camille Carroll, MD The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Global Kinetic. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scient. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. The institution of Dr. Carroll has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medscape. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Dr. Carroll has received research support from Parkinson's UK. The institution of Dr. Carroll has received research support from Edmond J Safra Foundation. The institution of Dr. Carroll has received research support from Cure Parkinson's. The institution of Dr. Carroll has received research support from Parkinson's UK. The institution of Dr. Carroll has received research support from NHSX.
Muhammad Ayub, MD Dr. Ayub has nothing to disclose.
Mohammad A. Sheikh, MBBS Dr. Sheikh has nothing to disclose.
Xiaochun Li No disclosure on file
Joao Vitor Mahler, MD Mr. Mahler Ferreira Oliveira has nothing to disclose.
Aaron W. Abrams, MD Dr. Abrams has nothing to disclose.
Laura Naydovich, MD Dr. Wolf has nothing to disclose.
Melinda S. Martin, PhD Dr. Martin has received personal compensation for serving as an employee of UCB. Dr. Martin has received stock or an ownership interest from UCB.
Michael T. Mullen, MD Dr. Mullen has received publishing royalties from a publication relating to health care.
John A. Lucas John A. Lucas has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Clinical Neuropsychology.
Kathryn B. Lalor, MD Dr. Lalor has nothing to disclose.
Jan-Mendelt Tillema, MD Dr. Tillema has nothing to disclose.
Giovanni Castellucci, MD, MS Dr. Castellucci has nothing to disclose.
Samira Apostolos-Pereira Samira Apostolos-Pereira has nothing to disclose.
Alexandra M. Livingston, DO An immediate family member of Dr. Livingston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Livingston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of an immediate family member of Dr. Livingston has received research support from Vertex. The institution of an immediate family member of Dr. Livingston has received research support from Roche. The institution of an immediate family member of Dr. Livingston has received research support from AstraZeneca. The institution of an immediate family member of Dr. Livingston has received research support from Enanta.
James R. Williams III, PhD Dr. Williams has received personal compensation for serving as an employee of Biogen. Dr. Williams has received stock or an ownership interest from Biogen.
Yu-Ting Chen, MD Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Nasima D. Shadbehr, DO Dr. Shadbehr has nothing to disclose.
Aashit K. Shah, MD, FAAN The institution of Dr. Shah has received research support from Eisai pharma .
Thomas A. Nelson, MD Dr. Nelson has nothing to disclose.
Asli Tuncer No disclosure on file
Hannah Irvine, MD Dr. Irvine has nothing to disclose.
Olivia Gilbert No disclosure on file
David M. Simpson, MD, FAAN Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Nilufer Taner, MD, PhD, FAAN The institution of Dr. Taner has received research support from NIH.
Nicholas Lannen, MD Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Anam K. Shaikh Miss Shaikh has nothing to disclose.
James W. Wheless, MD, FAAP, FAAN Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aquestive. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BioMarin. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Collin Culbertson, MD Dr. Culbertson has nothing to disclose.
Evan Riddle, PhD Dr. Riddle has received personal compensation for serving as an employee of Biogen. Dr. Riddle has received stock or an ownership interest from Biogen.
David Cantu, PhD Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Brian W. O'Mahony, MD Dr. O'Mahony has nothing to disclose.
Melike Cakan, MD Dr. Cakan has nothing to disclose.
David C. Wegener, Jr., MD Dr. Wegener has nothing to disclose.
Michael Gelfand, MD, PhD Dr. Gelfand has received personal compensation in the range of $0-$499 for serving as a Consultant for Aquestive. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. The institution of Dr. Gelfand has received research support from Aquestive. The institution of Dr. Gelfand has received research support from Xenon. The institution of Dr. Gelfand has received research support from Cerevel. The institution of Dr. Gelfand has received research support from UNEEG. The institution of Dr. Gelfand has received research support from Livanova. The institution of Dr. Gelfand has received research support from UCB. The institution of Dr. Gelfand has received research support from SK Pharma. The institution of Dr. Gelfand has received research support from Otsuka.
Suzete N. Farias Da Guarda, MD, PhD Prof. Farias Da Guarda has nothing to disclose.
Francis M. Filloux, MD Dr. Filloux has nothing to disclose.
Lauren B. Krupp, MD, FAAN Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lerhman. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medscape. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLive. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cleveland Clinic. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MCIC. The institution of Dr. Krupp has received research support from Biogen. The institution of Dr. Krupp has received research support from National Multiple Sclerosis Society. Dr. Krupp has received intellectual property interests from a discovery or technology relating to health care.
Paramita Saha-Chaudhuri No disclosure on file
Julia L. Jones, PhD Dr. Jones has received personal compensation for serving as an employee of The Medicine Group.
Georg Comes No disclosure on file
Mostafa Jafari, MD Dr. Jafari has nothing to disclose.
Elizabeth Seng, PhD Dr. Seng has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Seng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. The institution of Dr. Seng has received research support from NINDS.
Christopher Streib, MD Dr. Streib has nothing to disclose.
Kranthi K. Mandava Mr. Mandava has nothing to disclose.
Kaleb L. Culpepper, DO Dr. Culpepper has nothing to disclose.
Patrick Kwan Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EDUCOM SPA. Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Patrick Kwan has received research support from UCB. The institution of Patrick Kwan has received research support from Eisai.
Ashby Turner, MD Dr. Turner has nothing to disclose.
Qingliang Wang, MD PhD The institution of Dr. Wang has received research support from Maimonides Research & Development Foundation.
Anne-Liv Schulz No disclosure on file
David Bar-Or No disclosure on file
Yolanda Wheeler No disclosure on file
Koto Ishida, MD, FAAN Dr. Ishida has received publishing royalties from a publication relating to health care.
Kathryn Fitzgerald, PhD The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Louise M. McCarthy, MB BCh BAO Dr. McCarthy has nothing to disclose.
Ajay Goenka, MD Dr. Goenka has nothing to disclose.
Carroline Lobo, PhD Carroline Lobo has received personal compensation for serving as an employee of EMD Serono.
Danielle M. Hart Miss Hart has nothing to disclose.
Gogi Kumar, MD Dr. Kumar has nothing to disclose.
Erafat Rehim, MD Dr. Rehim has nothing to disclose.
Florin Floricel No disclosure on file
Moses Rodriguez, MD, FAAN Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Landon Oetjen, MD, PhD Dr. Oetjen has nothing to disclose.
Astrid Scheschonka No disclosure on file
Jeanne Feuerstein, MD The institution of Dr. Feuerstein has received research support from Mowry Fund Grant. The institution of Dr. Feuerstein has received research support from Davis Phinney. Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving as a Parkinson's Expert for Legal Case with Keating Wagner Palidori. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Attending Neurologist with VAMC. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Assistant Professor of Neurology with University of Colorado.
Omar Elsekaily, MBBS Dr. Elsekaily has nothing to disclose.
Samuel Frank, MD Dr. Frank has nothing to disclose.
Miguela Marie A. Senga, MD Dr. Senga has nothing to disclose.
Angie El-said Ms. El-said has nothing to disclose.
Olga Garcia-Bedoya No disclosure on file
Steven P. Sparagana, MD, FAAN Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nobelpharma. The institution of Dr. Sparagana has received research support from Greenwich Biosciences. The institution of Dr. Sparagana has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sparagana has received research support from Novartis. Dr. Sparagana has a non-compensated relationship as a Professional Advisory Board Member, committee member with Tuberous Sclerosis Alliance that is relevant to AAN interests or activities.
David K. Simon, MD, PhD Dr. Simon has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Bial Biotech. An immediate family member of Dr. Simon has stock in Biogen. The institution of Dr. Simon has received research support from Weston Brain Institute. The institution of Dr. Simon has received research support from NIH. The institution of Dr. Simon has received research support from Neuraly. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as a Steering Committee Member: SPARK clinical study with Biogen. Dr. Simon has received personal compensation in the range of $500-$4,999 for serving as a Steering Committee Member: NILO-PD clinical study with Michael J Fox Foundation.
Judy Opao, MD Dr. Opao has nothing to disclose.
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
Danny Samkutty, MD Dr. Samkutty has nothing to disclose.
Lara Carvalho de Oliveira Mrs. Carvalho de Oliveira has nothing to disclose.
Adam Ferguson No disclosure on file
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Aurora has stock in Impel Neurpharma.
Shalin D. Shah, MD Dr. Shah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eris.
Ankur Nayyar, MD Dr. Nayyar has nothing to disclose.
Jose J. Flores-Rivera, MD Dr. Flores-Rivera has nothing to disclose.
Myrna Cardiel, MD Dr. Cardiel has nothing to disclose.
Malak AlMojel, MD Dr. AlMojel has nothing to disclose.
Luis Molina Carrion, MD Dr. Molina Carrion has nothing to disclose.
Alyssa Bowling Ms. Bowling has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc.
Helena Gama Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A..
Tyrone Coleman, MD Mr. Coleman has nothing to disclose.
María F. Cedeño, MD Dr. Cedeño has nothing to disclose.
Shelly D. Ozark, MD Dr. Ozark has nothing to disclose.
David E. Kahn, MD An immediate family member of Dr. Kahn has received personal compensation for serving as an employee of Essai.
Rafaela F. Nascimento Miss Nascimento has nothing to disclose.
Jorg Wissel No disclosure on file
Alice Edwards, DO The institution of Dr. Rutatangwa has received research support from NIH.
Kereisha Donegal, MD Dr. Donegal has nothing to disclose.
Jose L. Ruiz-Sandoval, MD Dr. Ruiz-Sandoval has nothing to disclose.
Jeffrey W. Britton, MD, FAAN Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Aaron Desai, MD, MBBS No disclosure on file
Michael Waltz No disclosure on file
Jaime Kulisevsky, MD, PhD Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Esteve. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon.
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cleaview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Medical Comm. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Education Resource. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Education. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview.
Francisco Caiza Zambrano Mr. Caiza Zambrano has nothing to disclose.
Carmen Isasi No disclosure on file
Michael Strupp, MD, DO, FAAN Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio.
Patrick Fagan, MD Dr. Fagan has nothing to disclose.
Tomoko Kitago, MD Dr. Kitago has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MindMaze. The institution of Dr. Kitago has received research support from American Speech-Language Hearing Foundation. The institution of Dr. Kitago has received research support from National Institutes of Health.
Hamada H. Altalib, DO The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from Eisai. The institution of Dr. Altalib has received research support from Sunovian. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Kore K. Liow, MD, FACP The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Katelyn Stebbins Miss Stebbins has nothing to disclose.
Todd Kunkel, Other Mr. Kunkel has received personal compensation for serving as an employee of Collegium Pharmaceutical . Mr. Kunkel has stock in Collegium .
Barbara Voetsch, MD PhD Dr. Voetsch has nothing to disclose.
Tracy-Shi Zhang Fang, PhD Dr. ZHANG has nothing to disclose.
Sean Stern Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Gabriel Da Silva Avellar, MD No disclosure on file
Anne T. Berg, PhD Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded. Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. The institution of Dr. Berg has received research support from FamilieSCN2A Foundation.
Melody Badii, MD Dr. Badii has nothing to disclose.
Ricka Messer, MD Dr. Messer has nothing to disclose.
Tyler Lasky Tyler Lasky has received personal compensation for serving as an employee of Biogen. Tyler Lasky has stock in Biogen.
Steve Arcona, PhD Dr. Arcona has received personal compensation for serving as an employee of Cerevel. Dr. Arcona has stock in Cerevel.
Ricardo Murguia Fuentes, MD Dr. Murguia Fuentes has nothing to disclose.
Andrea Kuehn Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Nazire P. Acar Ozen, MD Dr. Acar Ozen has nothing to disclose.
Ahmer Asif, MD Dr. Asif has nothing to disclose.
Nicole Bou Rjeily, MD Dr. Bou Rjeily has nothing to disclose.
Yi-Bin Chen No disclosure on file
Jyoti Garg, MD Dr. Garg has nothing to disclose.
Tamara Strohm, MD Dr. Strohm has nothing to disclose.
Vijay Sardana, MD No disclosure on file
Tatiana T. Bremova-Ertl, MD, PhD Dr. Bremova-Ertl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrabio. The institution of Dr. Bremova-Ertl has received research support from InnoSuisse. Dr. Bremova-Ertl has received research support from Baasch-Medicus.
Lana Zhovtis Ryerson, MD Dr. Zhovtis Ryerson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zhovtis Ryerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Zhovtis Ryerson has received research support from Biogen. The institution of Dr. Zhovtis Ryerson has received research support from Genentech.
Anthony E. Lang, MD, FAAN Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions, Sun Pharma, Medichem, Medtronic, AbbVie and Sunovion. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received publishing royalties from a publication relating to health care.
Danielle Sandsmark, MD The institution of Dr. Sandsmark has received research support from NINDS.
Samy M. Guirguis, MD No disclosure on file
Kiran Bala, MD, MBBS Dr. Bala has nothing to disclose.
Page B. Pennell, MD, FAAN The institution of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Department of Defense. The institution of an immediate family member of Dr. Pennell has received research support from Environmental Protection Agency. The institution of an immediate family member of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Advanced Energy Consortium. Dr. Pennell has received publishing royalties from a publication relating to health care.
Robert T. Wechsler, MD, PhD, FAAN The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Raport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Rhoda Au, PhD Dr. Au has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Au has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Au has received publishing royalties from a publication relating to health care. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Davos Alzheimer's Collaborative. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with High Lantern.
Scott Patten, PhD Dr. Patten has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Canadian Psychiatric Association. Dr. Patten has received publishing royalties from a publication relating to health care.
Nauman Tariq, MD Dr. Tariq has received personal compensation for serving as an employee of NC neurological society .
Kristin Salottolo, MPH Ms. Salottolo has nothing to disclose.
Nazanin Sheibani, MD Dr. Sheibani has nothing to disclose.
Teresita Corona Vazquez No disclosure on file
Alizeh Shamshad Ms. Shamshad has nothing to disclose.
Philip Sjostedt Philip Sjostedt has received personal compensation for serving as an employee of The Medicine Group. Philip Sjostedt has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for SyNeBio.
Mahesh Chikkannaiah, MD Dr. Chikkannaiah has nothing to disclose.
Roger Cady, MD Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Susie Sinks No disclosure on file
Samhita Panda, MD, DM Dr. Panda has nothing to disclose.
Jianwen Cai No disclosure on file
Rohit Bhatia, MD, MBBS, DM Dr. Bhatia has nothing to disclose.
Beatriz Costa Miss Costa has nothing to disclose.
William G. Ondo, MD Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from Sun. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Butchi Raju Garuda, MD, FAAN Dr. Garuda has nothing to disclose.
Drishti Shah, PhD Dr. Shah has received personal compensation for serving as an employee of Takeda.
Juan C. Ayala Alvarez, MD Dr. Ayala Alvarez has nothing to disclose.
Laura A. Kirkpatrick, MD The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital.
Sarah Anthony, Other Ms. Anthony has nothing to disclose.
Abdullahi Musa Adamu, MBBS Dr. Adamu has nothing to disclose.
Ariana Stickel No disclosure on file
Gregory S. Aaen, MD Dr. Aaen has nothing to disclose.
Kristi M. Anderson, DO Dr. Anderson has nothing to disclose.
Kelsey Hillhouse, MD Dr. Carr has nothing to disclose.
Fazila Aseem, MD, MPH Dr. Aseem has nothing to disclose.
Jorge L. Morales, MD Dr. Morales has nothing to disclose.
Guilherme D. Silva, MD Dr. SILVA has nothing to disclose.
Mark R. Keezer, MD, PhD The institution of Dr. Keezer has received research support from UCB . The institution of Dr. Keezer has received research support from Eisai. The institution of Dr. Keezer has received research support from TD Bank. The institution of Dr. Keezer has received research support from Savoy Foundation. The institution of Dr. Keezer has received research support from TSC Alliance. The institution of Dr. Keezer has received research support from Quebec Bio-imaging Network. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Fonds de Recherche Québec Santé. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research.
Audrey Gabelle, MD No disclosure on file
Deepti Vibha, MD Dr. Vibha has nothing to disclose.
Clarence Wade No disclosure on file
Mattia Rosso, MD Dr. Rosso has nothing to disclose.
Preet M. Varade, MD Dr. Varade has nothing to disclose.
Marina K. Alvim Dr. Alvim has nothing to disclose.
Johnny Chen, Other Mr. Chen has nothing to disclose.
Tracy Dixon-Salazar, PhD Dr. Dixon-Salazar has received personal compensation for serving as an employee of Lennox-Gastaut Syndrome (LGS) Foundation. Dr. Dixon-Salazar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuelis.
Alissa A. Thomas, MD, FAAN Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Luciana V. Leon Cejas, MD Dr. Leon Cejas has nothing to disclose.
David Daniel, MD Dr. Daniel has nothing to disclose.
Lucas S. Silva, MD Dr. Silva has nothing to disclose.
Sandra Badial Ms. Badial has nothing to disclose.
Nathan P. Staff, MD, PhD, FAAN Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Hassan Jassim Al Hail, MD, FAAN Dr. Al Hail has nothing to disclose.
Nikita Shukla, MD The institution of Dr. Shukla has received research support from Roche.
Eduardo Nobile-Orazio, MD, PhD, FAAN Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Seo Youn Chang Miss Chang has nothing to disclose.
Katherine A. Zarroli, MD Dr. Zarroli has nothing to disclose.
Atef Kokash, DO Dr. Kokash has nothing to disclose.
Michael E. Reznik, MD Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Stuart H. Isaacson, MD, FAAN The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Rahul Damani No disclosure on file
Elizabeth B. Edwards Miss Edwards has nothing to disclose.
Jethro Hu, MD Dr. Hu has nothing to disclose.
Ali H. Abusrair, MD Dr. Abusrair has nothing to disclose.
Karen Smirnakis No disclosure on file
Luis Guedes, MD Mr. Guedes has received personal compensation for serving as an employee of BIAL - Portela & C.ª, S.A..
Shannon McWeeney No disclosure on file
Mathew Gregoski No disclosure on file
Luz Antonella A. Díaz Ledesma Miss Díaz Ledesma has nothing to disclose.
Boulenouar Mesraoua, MD, FAAN Dr. Mesraoua has nothing to disclose.
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Bayer, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen, Novartis, Merck, Roche, Sanofi.
Carlos De la Garza, MD Dr. De la Garza has nothing to disclose.
Clover Youn, MD Dr. Youn has nothing to disclose.
Peter C. Mabie, MD Dr. Mabie has nothing to disclose.
Renuka Verma No disclosure on file
Francisco Rocha Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Nasser Mohammed, MBBS Dr. Mohammed has nothing to disclose.
Soe S. Mar, MD, FAAN The institution of Dr. Mar has received research support from NIH.
Ryan Metzger, PhD An immediate family member of Dr. Metzger has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Metzger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Interpro Bioscience. An immediate family member of Dr. Metzger has stock in Ascendis. An immediate family member of Dr. Metzger has stock in Neurocrine Biosciences.
Sherry Danese No disclosure on file
Pradeep Kumar Gunasekaran No disclosure on file
Lalitha Sivaswamy, MD Dr. Sivaswamy has nothing to disclose.
Cleo Zarina A. Reyes, MD Dr. Reyes has nothing to disclose.
Ezequiel Gleichgerrcht, MD Dr. Gleichgerrcht has nothing to disclose.
Italo Karmann Aventurato, MD Dr. Karmann Aventurato has received research support from Coordenadoria de Aperfeiçoamento de Pessoal de Ensino Superior (CAPES). Dr. Karmann Aventurato has received research support from Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP).
Mandip S. Dhamoon, MD, MPH Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Abhay Ranjan No disclosure on file
Gian C. Rossi, DO Dr. Rossi has nothing to disclose.
Lisa Hobson-Webb, MD, FAAN An immediate family member of Dr. Hobson-Webb has received personal compensation for serving as an employee of G1 Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. The institution of Dr. Hobson-Webb has received research support from Sanofi Genzyme.
Xiao M. Androulakis, MD The institution of Dr. Androulakis has received research support from VA rehabilitation research .
Leigh E. Charvet, PhD Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Mancia M. Ko, Other Dr. Ko has received personal compensation for serving as an employee of Collegium Pharmaceutical.
Muhannad Seyam, MD Dr. Seyam has nothing to disclose.
Melika S. Jameie, MD Dr. Jameie has nothing to disclose.
Farah Wahbeh Ms. Wahbeh has nothing to disclose.
Julie Hviid Hahn-Pedersen No disclosure on file
Lauren Koffman, DO, MS Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm.
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Sharon Cohen, MD The institution of Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. The institution of Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for Diamond Therapeutics Inc.. The institution of Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ProMIS Neurosciences Inc.. The institution of Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RetiSpec Inc.. The institution of Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for College of Physicians and Surgeons of Ontario. The institution of Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CME Outfitters. The institution of Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Integritas. The institution of Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DBK Med.
David G. Vossler, MD, FAAN Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals.
Ashley Santilli, MD Dr. Santilli has nothing to disclose.
Vijayakumar Javalkar, MD, FAAN Dr. Javalkar has nothing to disclose.
Isabel Arrillaga-Romany, MD Dr. Arrillaga-Romany has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. The institution of Dr. Arrillaga-Romany has received research support from Astex Pharmaceuticals. The institution of Dr. Arrillaga-Romany has received research support from Gsk.
Leonardo Pipek, MD Mr. Pipek has nothing to disclose.
Chris M. Kozma No disclosure on file
David P. Lerner, MD Dr. Lerner has received publishing royalties from a publication relating to health care.
Heidi L. Henninger, MD, FAAN Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Henninger has received research support from UCB.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Sorleen Trevino, MD Dr. Trevino has nothing to disclose.
Hesham Masoud, MD Dr. Masoud has nothing to disclose.
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Abbie Chan Miss Chan has nothing to disclose.
Farhad Sahebkar-Moghaddam, MD Dr. Sahebkar-Moghaddam has received personal compensation for serving as an employee of Jazz pharmaceuticals. Dr. Sahebkar-Moghaddam has stock in Jazz pharmaceuticals.
David R. Cornblath, MD Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.
Daniah Shamim, MD Dr. Shamim has nothing to disclose.
Hayden W. Hall, DO Dr. Hall has nothing to disclose.
Connor Goo Mr. Goo has nothing to disclose.
Michelle X. Lu Miss Lu has nothing to disclose.
Michele Persico, MD Dr. Persico has nothing to disclose.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Sailaja Sanikommu, MBBS Dr. Sanikommu has nothing to disclose.
Carole Drexel Carole Drexel has nothing to disclose.
Karthik Bodhinathan, PhD Dr. Bodhinathan has received personal compensation for serving as an employee of TG Therapeutics. Dr. Bodhinathan has stock in TG Therapeutics.
Kun-Wei Song, MD Dr. Song has nothing to disclose.
M. S. Perry, MD Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for stoke therapeutics. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapeutics. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Biosciences. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Zogenix. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Biosciences.
Gabriela Trifan, MD Dr. Trifan has nothing to disclose.
Rana Karabudak, MD Dr. Karabudak has nothing to disclose.
Pierpaolo Turcano, MD Dr. Turcano has nothing to disclose.
Obiefuna A. Nwabueze, MD Dr. Nwabueze has nothing to disclose.
Dwight Barry No disclosure on file
Inder Puri, MD, MBBS Dr. Puri has nothing to disclose.
Steve S. Chung, MD, FAAN The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Melissa Lamar No disclosure on file
Gayane R. Melikyan, MD, FAAN Dr. Melikyan has nothing to disclose.
Suemin J. Yoon, MD Dr. Yoon has nothing to disclose.
Ali Mahta, MD Dr. Mahta has nothing to disclose.
Brian Nahed No disclosure on file
Michelle P. Lin, MD Dr. Lin has nothing to disclose.
Janice Wong, MD Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Nasrin Rahimian, MD Dr. Rahimian has nothing to disclose.
Jorg Dietrich, MD, PhD, FAAN Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Varina Boerwinkle, MD Dr. Boerwinkle has nothing to disclose.
Kaitlin Seibert, MD The institution of Dr. Seibert has received research support from Retirement Research Foundation. The institution of Dr. Seibert has received research support from Center for Healthcare Delivery Science and Innovation.
Yakeel Quiroz, PhD Dr. Quiroz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Quiroz has received intellectual property interests from a discovery or technology relating to health care.
Hisham R. Salahuddin, MD Dr. Salahuddin has nothing to disclose.
Jose R. McFaline-Figueroa, MD, PhD Dr. McFaline-Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. McFaline-Figueroa has received research support from National Brain Tumor Society. The institution of Dr. McFaline-Figueroa has received research support from National Institutes of Health. The institution of Dr. McFaline-Figueroa has received research support from Robert Wood Johnson Foundation.
Jeffrey Kuerbitz, PhD Dr. Kuerbitz has nothing to disclose.
Lindsay Tetreault, MD, PhD Dr. Tetreault has nothing to disclose.
Shambaditya Das, Jr., MD, MBBS Dr. Das has nothing to disclose.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Immune Sciences. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arcellx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Genentech. The institution of Dr. Habib has received research support from Regeneron.
Lawrence A. Zeidman, MD, FAAN Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Zeidman has received research support from Octapharma. Dr. Zeidman has received publishing royalties from a publication relating to health care.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Michael Althaus Michael Althaus has received personal compensation for serving as an employee of Merz Pharmaceuticals.
Naim I. Haddad, MD, FAAN Dr. Haddad has nothing to disclose.
Elizabeth Thiele, MD Dr. Thiele has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. An immediate family member of Dr. Thiele has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thor labs. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for takeda. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics.
Ariyaporn Haripottawekul Miss Haripottawekul has nothing to disclose.
Dagoberto Callegaro, Sr., PhD Dr. Callegaro has nothing to disclose.
Huda Alalami, MD Dr. Alalami has nothing to disclose.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemix, Inc. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pinteon Therapeutics. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from NovaSignal . Dr. Diaz-Arrastia has received stock or an ownership interest from Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Kevin Spiegler, MD, PhD Dr. Spiegler has nothing to disclose.
Sarah L. Wyckoff, BS Ms. Wyckoff has nothing to disclose.
Carlos A. Perez, MD Dr. Perez has received personal compensation for serving as an employee of Sanofi-Genzyme.
Meredith F. Yang Ms. Yang has nothing to disclose.
Sadia Waheed, MBBS Dr. Waheed has nothing to disclose.
Rebecca Traub, MD, FAAN Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext.
Sarada Sakamuri, MD Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with AANEM.
Hanah A. Imam, MBBS Dr. Imam has nothing to disclose.
Yasaman Pirahanchi, MD Dr. Pirahanchi has nothing to disclose.
Ronak U. Trivedi Mr. Trivedi has nothing to disclose.
Chandra Sekhar Mannyam, MBBS Dr. Mannyam has nothing to disclose.
Hussam A. Yacoub, DO Dr. Yacoub has nothing to disclose.
Biman K. Ray, MD Dr. Ray has nothing to disclose.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ayush Agarwal, DM Dr. Agarwal has nothing to disclose.
Grace L. Liang, MD Dr. Liang has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Liang has stock in Neurocrine Biosciences.
Michael R. Sperling, MD, FAAN Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Marc Gebara Mr. Gebara has nothing to disclose.
Ellen M. Mowry, MD, FAAN Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BeCareLink, LLC. The institution of Dr. Mowry has received research support from Biogen. The institution of Dr. Mowry has received research support from Genentech. Dr. Mowry has received publishing royalties from a publication relating to health care.
Michael A. Figueroa, DO Dr. Figueroa has nothing to disclose.
Yohei Harada, MD Dr. Harada has nothing to disclose.
Daniel H. Lench, PhD Dr. Lench has nothing to disclose.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Christian Lachner No disclosure on file
Dirk T. Deleu, MD, PhD, FRCP, FAAN Dr. Deleu has nothing to disclose.
Ivan Roque Sanchez, MD Dr. Roque Sanchez has nothing to disclose.
Ankita Ghosh, MD Dr. Ghosh has nothing to disclose.
Ashley Weng, MD Dr. Weng has nothing to disclose.
Junaid Ansari, MD Dr. Ansari has nothing to disclose.
Aayushi Garg, MBBS Dr. Garg has nothing to disclose.
Asif Doja, MD, FAAN Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for the CMPA. Dr. Doja has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Integra . Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Connect Care .
Amrita Pandey, MD Dr. PANDEY has nothing to disclose.
Sayyeda Zahra, MD Dr. Zahra has nothing to disclose.
Joana Moreira Joana Moreira has received personal compensation for serving as an employee of BIAL.
Maria Martinez-Lage, MD The institution of Dr. Martinez-Lage has received research support from NIH.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Daniel Fernandez-Guzman No disclosure on file
Muhammed Ors Mr. Ors has nothing to disclose.
Raghav Talreja, MD Mr. Talreja has nothing to disclose.
Ivan Murrieta-Alvarez, MD Dr. Murrieta-Alvarez has nothing to disclose.
Aashka Ponda, Other Dr. Ponda has nothing to disclose.
Shaheen Sombans, MBBS Dr. Sombans has nothing to disclose.
Jintong Liu Miss Liu has nothing to disclose.
Denise Li, MD Dr. Li has nothing to disclose.
Frank Tennigkeit, PhD Dr. Tennigkeit has received personal compensation for serving as an employee of UCB Biosciences. Dr. Tennigkeit has stock in UCB Biosciences.
Matt Hobbs Mr. Hobbs has received personal compensation for serving as an employee of Biogen. Mr. Hobbs has stock in Biogen.
Rafael Joao Mr. Joao has nothing to disclose.
Alison M. Pack, MD, FAAN An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care.
Eric Jen Eric Jen has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Sarah R. Durica, MD An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Ramsha A. Bhutta, MD Dr. Bhutta has nothing to disclose.
Marco M. Wolmarans Mr. Wolmarans has nothing to disclose.
Chindo B. Mallum, MD Dr. Mallum has nothing to disclose.
Denise K. Sebasigari, MD Dr. Sebasigari has nothing to disclose.
Ashley Bailey, MD Dr. Bailey has nothing to disclose.
Saba Ilkhani, MD Miss Ilkhani has nothing to disclose.
Nancy Song, MD Dr. Song has nothing to disclose.
Nikoloz Karazanashvili, MD Dr. Karazanashvili has nothing to disclose.
Catherine L. Passariello, PhD Dr. Passariello has received personal compensation for serving as an employee of Jazz Pharmaceuticals . Dr. Passariello has stock in Jazz Pharmaceuticals . An immediate family member of Dr. Passariello has stock in UCB Pharmaceuticals . Dr. Passariello has received intellectual property interests from a discovery or technology relating to health care.
Murtaza Khan, MD Dr. Khan has nothing to disclose.
Jessica DuHaime, PharmD Dr. DuHaime has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. DuHaime has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. DuHaime has stock in Jazz Pharmaceuticals.
Larry Charleston IV, MD, MSc, FAHS Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven Biopharmaceuticals. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member at Large with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.